Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,382 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Genomic Predictors of Recurrent Pregnancy Loss

for
Recurrent Pregnancy Loss
Location: Chicago IL, Detroit MI, Hershey PA, Baltimore MD,
Sponsor: Yale University

Sex: All

Age: 18 - 50

Code: NCT05444283

Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for
Gastric Adenocarcinoma,
Location: Chicago IL, Oak Brook IL, Warrenville IL, Geneva IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Chicago IL, Zion IL, Milwaukee WI, Rochester MN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Chicago IL, Maywood IL, Oak Lawn IL, Park Ridge IL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase2, Phase3, Recruiting

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT07427017

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders

for
Sleep Apnea Obstructive (OSA)
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 60

Code: NCT06926036

Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Aurora IL, Yorkville IL, Saint Joseph MI, Ottawa IL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

for
Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
Location: Chicago IL, St Louis MO, Nashville TN, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06858813

Phase1, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Chicago IL, West Lafayette IN, Detroit MI,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Chicago IL, Grand Rapids MI, Detroit MI, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase1, Phase2, Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Chicago IL, Grand Rapids MI, Cincinnati OH,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

Predict Severe Traumatic Brain Injury

for
Traumatic Brain Injury
Location: Chicago IL, Houston TX
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06966713

Recruiting

Rett Syndrome Registry

for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Chicago IL, Cincinnati OH, St Louis MO, Columbus OH,
Sponsor: International Rett Syndrome Foundation

Sex: All

Age: 0 - 70+

Code: NCT05432349

Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

for
Metastatic Colorectal Cancer
Location: Chicago IL, Grand Rapids MI, Nashville TN, Pikeville KY,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06252649

Phase3, Recruiting

Procedural Framing and Epidural Steroid Injection Outcomes

for
Lumbosacral Radiculopathy
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 0+

Code: NCT07498140

Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Chicago IL, Naperville IL, Kenosha WI, Madison WI,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

for
Alopecia Areata
Location: Chicago IL, Plainfield IN, Kenosha WI, Indianapolis IN,
Sponsor: AnaptysBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05205070

Phase2, Recruiting

US National OCS Heart Perfusion (OHP) Registry

for
Heart Transplant
Location: Chicago IL, Milwaukee WI, Ann Arbor MI, Detroit MI,
Sponsor: TransMedics

Sex: All

Age: 0+

Code: NCT05915299

Recruiting

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Chicago IL, Cleveland OH, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06015880

Phase1, Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Chicago IL, Iowa City IA, St Louis MO, Des Moines IA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase3, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago